Brief: Grifols Expands Diagnostic Production Capacity In US With New Plant In San Diego
16/10/2025 13:13
Oct 16 (Reuters) - Grifols SA GRLS.MC: EXPANDS ITS DIAGNOSTIC PRODUCTION CAPACITY IN US WITH NEW PLANT IN SAN DIEGO BEGINS MANUFACTURING DG GEL CARDS AND RED BLOOD CELL REAGENTS Further company coverage: GRLS.MC (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Grifols
See all newsSpanish stocks - Factors to watch on Nov 3
Brief: Grifols Approves Interim Dividend Of €0.15/Shr Payable On Dec 4
Brief: Grifols Q3 Group Profit €162 Mln
Refile: Grifols says Canada plasma license suspension has no impact on ongoing operations
Brief: Health Canada Suspends Licence Of Grifols Site In Winnipeg - Globe And Mail